Preclinical pharmacology of 2-methoxyantimycin A compounds as novel antitumor agents

被引：0
|
作者：
Hui Wang
Mao Li
Julie K. Rhie
David M. Hockenbery
Joseph M. Covey
Ruiwen Zhang
Donald L. Hill
机构：
[1] University of Alabama,Department of Pharmacology and Toxicology, Division of Clinical Pharmacology, Cancer Pharmacology Laboratory, Comprehensive Cancer Center
[2] National Cancer Institute,undefined
[3] Fred Hutchinson Cancer Research Center,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2005年 / 56卷
关键词：
2-Methoxyantimycin A; HPLC; Metabolism; Protein binding; Pharmacokinetics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：291 / 298
页数：7
相关论文
共 50 条
  • [1] Preclinical pharmacology of 2-methoxyantimycin A compounds as novel antitumor agents
    Wang, H
    Li, M
    Rhie, JK
    Hockenbery, DM
    Covey, JM
    Zhang, RW
    Hill, DL
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2005, 56 (03) : 291 - 298
  • [2] Gold Compounds as Anticancer Agents: Chemistry, Cellular Pharmacology, and Preclinical Studies
    Nobili, Stefania
    Mini, Enrico
    Landini, Ida
    Gabbiani, Chiara
    Casini, Angela
    Messori, Luigi
    MEDICINAL RESEARCH REVIEWS, 2010, 30 (03) : 550 - 580
  • [3] Preclinical Pharmacology of mGlu2/3 Receptor Agonists: Novel Agents for Schizophrenia?
    Schoepp, Darryle D.
    Marek, Gerard J.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2002, 1 (02) : 215 - 225
  • [4] PRECLINICAL EVALUATION OF ANTITUMOR AGENTS
    GOLDIN, A
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1971, (NSEP): : 10 - &
  • [5] PRECLINICAL EVALUATION OF ANTITUMOR AGENTS
    GOLDIN, A
    CHEMICAL TECHNOLOGY, 1972, 2 (07): : 424 - &
  • [6] Preclinical pharmacology of epothilone D, a novel tubulin-stabilizing antitumor agent
    Hui Wang
    Zhi Wang
    Shuyi Wang
    Mao Li
    Li Nan
    Julie K. Rhie
    Joseph M. Covey
    Ruiwen Zhang
    Donald L. Hill
    Cancer Chemotherapy and Pharmacology, 2005, 56 : 255 - 260
  • [7] Preclinical pharmacology of epothilone D, a novel tubulin-stabilizing antitumor agent
    Wang, H
    Wang, Z
    Wang, SY
    Li, M
    Nan, L
    Rhie, JK
    Covey, JM
    Zhang, RW
    Hill, DL
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2005, 56 (03) : 255 - 260
  • [8] Novel heparan sulfate mimetic compounds as antitumor agents
    Ishida, K
    Wierzba, MK
    Teruya, T
    Simizu, S
    Osada, H
    CHEMISTRY & BIOLOGY, 2004, 11 (03): : 367 - 377
  • [9] MOLECULAR PHARMACOLOGY OF CERTAIN ANTITUMOR AGENTS
    GROLLMAN, AP
    HORWITZ, SB
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1975, 170 (AUG24): : 29 - 29
  • [10] ENDOCRINE PHARMACOLOGY OF ANTIESTROGENS AS ANTITUMOR AGENTS
    JORDAN, VC
    MURPHY, CS
    ENDOCRINE REVIEWS, 1990, 11 (04) : 578 - 610
12345